Following Donald Trump's election as US President, Indian investors are evaluating the potential effects of his proposed trade policies. While some analysts predict difficulties for Indian exporters, particularly in pharmaceuticals and IT, others believe that sectors like EMS and chemicals could benefit from a 'China +1' strategy among US companies.